2Luke B, Brown MB, Morbeck DE, et al. Factors associated with ovarian hyper stimulation syndrome (OHSS) and effect on assisted reproductive lutechnology (ART) treatment and outcome [ J ]. Fertil steril, 2010, 94(4): 1399-404.
3Binder H, Dietrich R, Windaus F, et al. Update on ovarian hyper stimulation syndrome : Part Ⅰ - incidence and pathogenesis [ J ]. Int J Fertil-Women Med, 2007, 52 (1): 11.
4Ajonuma LC. Is vascular endothelial growth factor (VEGF) the main mediator in ovarian hyper stimulation syndrome (OHSS) ? [ J ]. Medical Hypotheses,2008,70 (3) : 1174 - 1178.
5Palembang S, et al. Compiegne citrate, met form citrate, met form or both as first - step approach in treating anovulatory infertility in patients with polycystic ovary syndrome (PCOS) : a systematic review of head- to -head randomized controlled studies and meta -analysis [J]. Clin Endocrinal (Oxfam), 2009, 70(2): 311 -321.
6Enqmann L, et al. The use of gonadotropin - releasing hormone ( Gn- RH) to induce oocyte maturation after co treatment with GnRH antagonist in high risk patients undergoing in vitro fertilization prevent the risk of ovarian hyper stimulation syndrome: a prospective randomized controlled study[J]. Fertil Steril, 2008, 89( 1 ) : 84 -91.
